Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Large-scale assessment of the gliomasphere model system.

Laks DR, Crisman TJ, Shih MY, Mottahedeh J, Gao F, Sperry J, Garrett MC, Yong WH, Cloughesy TF, Liau LM, Lai A, Coppola G, Kornblum HI.

Neuro Oncol. 2016 Oct;18(10):1367-78. doi: 10.1093/neuonc/now045.

PMID:
27116978
2.

Human Adipose Tissue-Derived Mesenchymal Stem Cells Target Brain Tumor-Initiating Cells.

Choi SA, Lee JY, Kwon SE, Wang KC, Phi JH, Choi JW, Jin X, Lim JY, Kim H, Kim SK.

PLoS One. 2015 Jun 15;10(6):e0129292. doi: 10.1371/journal.pone.0129292. Erratum in: PLoS One. 2015;10(7):e0132877.

3.

p75 neurotrophin receptor cleavage by α- and γ-secretases is required for neurotrophin-mediated proliferation of brain tumor-initiating cells.

Forsyth PA, Krishna N, Lawn S, Valadez JG, Qu X, Fenstermacher DA, Fournier M, Potthast L, Chinnaiyan P, Gibney GT, Zeinieh M, Barker PA, Carter BD, Cooper MK, Kenchappa RS.

J Biol Chem. 2014 Mar 21;289(12):8067-85. doi: 10.1074/jbc.M113.513762.

4.

Reciprocal activation of transcription factors underlies the dichotomy between proliferation and invasion of glioma cells.

Dhruv HD, McDonough Winslow WS, Armstrong B, Tuncali S, Eschbacher J, Kislin K, Loftus JC, Tran NL, Berens ME.

PLoS One. 2013 Aug 15;8(8):e72134. doi: 10.1371/journal.pone.0072134.

5.

The implications of cancer stem cells for cancer therapy.

Jiang W, Peng J, Zhang Y, Cho WC, Jin K.

Int J Mol Sci. 2012 Dec 5;13(12):16636-57. doi: 10.3390/ijms131216636. Review.

6.

Siomycin A targets brain tumor stem cells partially through a MELK-mediated pathway.

Nakano I, Joshi K, Visnyei K, Hu B, Watanabe M, Lam D, Wexler E, Saigusa K, Nakamura Y, Laks DR, Mischel PS, Viapiano M, Kornblum HI.

Neuro Oncol. 2011 Jun;13(6):622-34. doi: 10.1093/neuonc/nor023.

7.

A small molecule accelerates neuronal differentiation in the adult rat.

Wurdak H, Zhu S, Min KH, Aimone L, Lairson LL, Watson J, Chopiuk G, Demas J, Charette B, Halder R, Weerapana E, Cravatt BF, Cline HT, Peters EC, Zhang J, Walker JR, Wu C, Chang J, Tuntland T, Cho CY, Schultz PG.

Proc Natl Acad Sci U S A. 2010 Sep 21;107(38):16542-7. doi: 10.1073/pnas.1010300107. Erratum in: Proc Natl Acad Sci U S A. 2010 Dec 21;107(51):22360. Halder, Rajkumar [added].

8.

Brain tumor stem cells as therapeutic targets in models of glioma.

Laks DR, Visnyei K, Kornblum HI.

Yonsei Med J. 2010 Sep;51(5):633-40. doi: 10.3349/ymj.2010.51.5.633. Review.

9.

Neural precursor cells and central nervous system radiation sensitivity.

Fike JR, Rosi S, Limoli CL.

Semin Radiat Oncol. 2009 Apr;19(2):122-32. doi: 10.1016/j.semradonc.2008.12.003. Review.

10.

Notch: from neural development to neurological disorders.

Lathia JD, Mattson MP, Cheng A.

J Neurochem. 2008 Dec;107(6):1471-81. doi: 10.1111/j.1471-4159.2008.05715.x. Review.

11.

Gliotypic neural stem cells transiently adopt tumorigenic properties during normal differentiation.

Walton NM, Snyder GE, Park D, Kobeissy F, Scheffler B, Steindler DA.

Stem Cells. 2009 Feb;27(2):280-9. doi: 10.1634/stemcells.2008-0842.

12.

Epigenetic principles and mechanisms underlying nervous system functions in health and disease.

Mehler MF.

Prog Neurobiol. 2008 Dec 11;86(4):305-41. doi: 10.1016/j.pneurobio.2008.10.001. Review.

13.

The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells.

Bidlingmaier S, Zhu X, Liu B.

J Mol Med (Berl). 2008 Sep;86(9):1025-32. doi: 10.1007/s00109-008-0357-8. Review.

14.

A role for the transcription factor HEY1 in glioblastoma.

Hulleman E, Quarto M, Vernell R, Masserdotti G, Colli E, Kros JM, Levi D, Gaetani P, Tunici P, Finocchiaro G, Baena RR, Capra M, Helin K.

J Cell Mol Med. 2009 Jan;13(1):136-46. doi: 10.1111/j.1582-4934.2008.00307.x.

15.

Tumor cells from ultrasonic aspirations of glioblastomas migrate and form spheres with radial outgrowth.

Beckner ME, Jane EP, Jankowitz B, Agostino NR, Walter KA, Hamilton RL, Pollack IF.

Cancer Lett. 2007 Sep 18;255(1):135-44.

16.

Angiogenesis-independent tumor growth mediated by stem-like cancer cells.

Sakariassen PØ, Prestegarden L, Wang J, Skaftnesmo KO, Mahesparan R, Molthoff C, Sminia P, Sundlisaeter E, Misra A, Tysnes BB, Chekenya M, Peters H, Lende G, Kalland KH, Øyan AM, Petersen K, Jonassen I, van der Kogel A, Feuerstein BG, Terzis AJ, Bjerkvig R, Enger PØ.

Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16466-71.

Items per page

Supplemental Content

Support Center